Selected research
Industry Research
Omadacycline API Industry Research Report 2026
Market perspective
The global Omadacycline API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Omadacycline API is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Omadacycline API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Omadacycline API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Omadacycline API include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Omadacycline API market in revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Omadacycline API.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Omadacycline API Market by Company
Sichuan Qingmu Pharmaceutical
Sichuan Kelun Pharmaceutical
Sichuan Aobang Gude Pharmaceutical
Shanghai Desano Chemical Pharmaceutical
Asymchem Laboratories
Hubei Tianshu Pharmaceutical
Paratek Pharmaceuticals
Omadacycline API Segment by Type
Purity 97%-99%
Purity Above 99%
Omadacycline API Segment by Application
Injection
Tablets
Omadacycline API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omadacycline API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Omadacycline API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omadacycline API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Omadacycline API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Omadacycline API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Omadacycline API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 97%-99%
- Purity Above 99%
Applications
- Injection
- Tablets
Companies covered
- Sichuan Qingmu Pharmaceutical
- Sichuan Kelun Pharmaceutical
- Sichuan Aobang Gude Pharmaceutical
- Shanghai Desano Chemical Pharmaceutical
- Asymchem Laboratories
- Hubei Tianshu Pharmaceutical
- Paratek Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Omadacycline API by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Purity 97%-99%
- 2.2.3 Purity Above 99%
- 2.3 Omadacycline API by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Tablets
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Omadacycline API Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Omadacycline API Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Omadacycline API Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Omadacycline API Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Omadacycline API Production by Manufacturers (2021-2026)
- 3.2 Global Omadacycline API Production Value by Manufacturers (2021-2026)
- 3.3 Global Omadacycline API Average Price by Manufacturers (2021-2026)
- 3.4 Global Omadacycline API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Omadacycline API Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Omadacycline API Manufacturers, Product Type & Application
- 3.7 Global Omadacycline API Manufacturers Established Date
- 3.8 Global Omadacycline API Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sichuan Qingmu Pharmaceutical
- 4.1.1 Sichuan Qingmu Pharmaceutical Omadacycline API Company Information
- 4.1.2 Sichuan Qingmu Pharmaceutical Omadacycline API Business Overview
- 4.1.3 Sichuan Qingmu Pharmaceutical Omadacycline API Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Sichuan Qingmu Pharmaceutical Product Portfolio
- 4.1.5 Sichuan Qingmu Pharmaceutical Recent Developments
- 4.2 Sichuan Kelun Pharmaceutical
- 4.2.1 Sichuan Kelun Pharmaceutical Omadacycline API Company Information
- 4.2.2 Sichuan Kelun Pharmaceutical Omadacycline API Business Overview
- 4.2.3 Sichuan Kelun Pharmaceutical Omadacycline API Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Sichuan Kelun Pharmaceutical Product Portfolio
- 4.2.5 Sichuan Kelun Pharmaceutical Recent Developments
- 4.3 Sichuan Aobang Gude Pharmaceutical
- 4.3.1 Sichuan Aobang Gude Pharmaceutical Omadacycline API Company Information
- 4.3.2 Sichuan Aobang Gude Pharmaceutical Omadacycline API Business Overview
- 4.3.3 Sichuan Aobang Gude Pharmaceutical Omadacycline API Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Sichuan Aobang Gude Pharmaceutical Product Portfolio
- 4.3.5 Sichuan Aobang Gude Pharmaceutical Recent Developments
- 4.4 Shanghai Desano Chemical Pharmaceutical
- 4.4.1 Shanghai Desano Chemical Pharmaceutical Omadacycline API Company Information
- 4.4.2 Shanghai Desano Chemical Pharmaceutical Omadacycline API Business Overview
- 4.4.3 Shanghai Desano Chemical Pharmaceutical Omadacycline API Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Shanghai Desano Chemical Pharmaceutical Product Portfolio
- 4.4.5 Shanghai Desano Chemical Pharmaceutical Recent Developments
- 4.5 Asymchem Laboratories
- 4.5.1 Asymchem Laboratories Omadacycline API Company Information
- 4.5.2 Asymchem Laboratories Omadacycline API Business Overview
- 4.5.3 Asymchem Laboratories Omadacycline API Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Asymchem Laboratories Product Portfolio
- 4.5.5 Asymchem Laboratories Recent Developments
- 4.6 Hubei Tianshu Pharmaceutical
- 4.6.1 Hubei Tianshu Pharmaceutical Omadacycline API Company Information
- 4.6.2 Hubei Tianshu Pharmaceutical Omadacycline API Business Overview
- 4.6.3 Hubei Tianshu Pharmaceutical Omadacycline API Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Hubei Tianshu Pharmaceutical Product Portfolio
- 4.6.5 Hubei Tianshu Pharmaceutical Recent Developments
- 4.7 Paratek Pharmaceuticals
- 4.7.1 Paratek Pharmaceuticals Omadacycline API Company Information
- 4.7.2 Paratek Pharmaceuticals Omadacycline API Business Overview
- 4.7.3 Paratek Pharmaceuticals Omadacycline API Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Paratek Pharmaceuticals Product Portfolio
- 4.7.5 Paratek Pharmaceuticals Recent Developments
5 Global Omadacycline API Production by Region
- 5.1 Global Omadacycline API Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Omadacycline API Production by Region: 2021-2032
- 5.2.1 Global Omadacycline API Production by Region: 2021-2026
- 5.2.2 Global Omadacycline API Production Forecast by Region (2027-2032)
- 5.3 Global Omadacycline API Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Omadacycline API Production Value by Region: 2021-2032
- 5.4.1 Global Omadacycline API Production Value by Region: 2021-2026
- 5.4.2 Global Omadacycline API Production Value Forecast by Region (2027-2032)
- 5.5 Global Omadacycline API Market Price Analysis by Region (2021-2026)
- 5.6 Global Omadacycline API Production and Value, YOY Growth
- 5.6.1 North America Omadacycline API Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Omadacycline API Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Omadacycline API Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Omadacycline API Production Value Estimates and Forecasts (2021-2032)
6 Global Omadacycline API Consumption by Region
- 6.1 Global Omadacycline API Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Omadacycline API Consumption by Region (2021-2032)
- 6.2.1 Global Omadacycline API Consumption by Region: 2021-2026
- 6.2.2 Global Omadacycline API Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Omadacycline API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Omadacycline API Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Omadacycline API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Omadacycline API Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Omadacycline API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Omadacycline API Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Omadacycline API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Omadacycline API Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Omadacycline API Production by Type (2021-2032)
- 7.1.1 Global Omadacycline API Production by Type (2021-2032) & (kg)
- 7.1.2 Global Omadacycline API Production Market Share by Type (2021-2032)
- 7.2 Global Omadacycline API Production Value by Type (2021-2032)
- 7.2.1 Global Omadacycline API Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Omadacycline API Production Value Market Share by Type (2021-2032)
- 7.3 Global Omadacycline API Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Omadacycline API Production by Application (2021-2032)
- 8.1.1 Global Omadacycline API Production by Application (2021-2032) & (kg)
- 8.1.2 Global Omadacycline API Production Market Share by Application (2021-2032)
- 8.2 Global Omadacycline API Production Value by Application (2021-2032)
- 8.2.1 Global Omadacycline API Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Omadacycline API Production Value Market Share by Application (2021-2032)
- 8.3 Global Omadacycline API Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Omadacycline API Value Chain Analysis
- 9.1.1 Omadacycline API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Omadacycline API Production Mode & Process
- 9.2 Omadacycline API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Omadacycline API Distributors
- 9.2.3 Omadacycline API Customers
10 Global Omadacycline API Analyzing Market Dynamics
- 10.1 Omadacycline API Industry Trends
- 10.2 Omadacycline API Industry Drivers
- 10.3 Omadacycline API Industry Opportunities and Challenges
- 10.4 Omadacycline API Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst